Astera Labs Insider Selling Surge: Execs Dump 5% Shares Amid 25% Monthly Decline, Hinting at Over‑Valuation Concerns
Insider selling at Astera Labs signals a potential valuation peak amid volatility and high P/E; investors should weigh disciplined 10b‑5‑1 sales against the company’s AI‑infrastructure growth prospects.
4 minutes to read

